Search - tctmd.com

Displaying 661 - 680 of 1726

Sort: Relevancy | Date

Presentation TCT 2017

Exploring Diversity and Generalizability of EXCEL/NOBLE III: Fu-Wai Left Main Registry

Presenter: Antonio Colombo, David E. Kandzari, Bo Xu

October 31, 2017

Presentation TCT 2017

Exploring Diversity and Generalizability of EXCEL/NOBLE II: IRIS-MAIN

Presenter: Antonio Colombo, David E. Kandzari, Duk-Woo Park

October 31, 2017

Presentation TCT 2017

Exploring Diversity and Generalizability of EXCEL/NOBLE I: DELTA-2

Presenter: Antonio Colombo, David E. Kandzari, Alaide Chieffo

October 31, 2017

Presentation TCT 2017

Insights From the PCI Arms in EXCEL and NOBLE: Can the Outcomes Be Further Improved?

Presenter: Antonio Colombo, David E. Kandzari, Marie-Claude Morice

October 31, 2017

Presentation TCT 2017

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Presenter: Azeem Latib, Dean J. Kereiakes

October 31, 2017

Presentation TCT 2017

Insights From the CABG Arms in EXCEL and NOBLE: What Met Expectations, What Didnt?

Presenter: Antonio Colombo, David E. Kandzari, John D. Puskas

October 31, 2017

Presentation TCT 2017

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

Presenter: Azeem Latib, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

Insights From New Meta-Analyses of PCI vs CABG for Left Main Revascularization

Presenter: Antonio Colombo, David E. Kandzari, Davide Capodanno

October 31, 2017

Presentation TCT 2017

ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption

Presenter: Azeem Latib, Bernard R. Chevalier

October 31, 2017

Presentation TCT 2017

NOBLE: Core Findings Revisited and New Data

Presenter: Antonio Colombo, David E. Kandzari, Evald H. Christiansen

October 31, 2017

Presentation TCT 2017

ABSORB in STEMI I: TROFI II 3-Year Clinical Outcomes and Correlations With the 6-Month OCT Findings

Presenter: Azeem Latib, Manel Sabate

October 31, 2017

Presentation TCT 2017

New Insights From AIDA: Subgroups and Predictors of Adverse Events

Presenter: Azeem Latib, Joanna J. Wykrzykowska

October 31, 2017

Presentation TCT 2017

TCT 571: Different Tissue Morphology of In-stent Restenosis in Hemodialysis Patient Compared With Non-hemodialysis Patients: A Prospective Multicenter Optical Coherence Tomography Registry

Presenter: Francesco Prati, Renu Virmani, Yoshinori Nagasawa, MD

October 31, 2017

Presentation TCT 2017

RIBS IV: 3-Year Outcomes From a Randomized Trial of a Metallic DES vs a Drug-Eluting Balloon in Patients With DES Restenosis

Presenter: Thomas F. Luscher, Fernando Alfonso

October 31, 2017

Presentation TCT 2017

Bioresorbable Scaffolds One Year After Approval: FDA Perspectives on Current and Future BRS

Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Andrew Farb

October 31, 2017

Presentation TCT 2017

Bioresorbable Scaffolds One Year After Approval: Physician-scientist Perspectives on Current and Future BRS

Presenter: Mitchell W. Krucoff, P.F. Adrian Magee, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

TCT 16: Prospective, Multicenter Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold - Imaging Outcomes and Five-Year Clinical and Imaging Results

Presenter: Stephan Achenbach, Jacques J. Koolen, Stefan Verheye

October 31, 2017

Presentation TCT 2017

ILUMIEN III: 1-Year Outcomes From a Randomized Trial of OCT-Guided vs IVUS-Guided vs Angiography-Guided Stent Implantation

Presenter: Thomas F. Luscher, Ziad A. Ali

October 31, 2017

Presentation TCT 2017

TCT 94: Safety and Efficacy of the Combo Bioegineered Stent in an All-Comer PCI Cohort - Results From the Mascot Postmarketing Registry

Presenter: Francesco Prati, Renu Virmani, Antonio Colombo

October 31, 2017

Presentation TCT 2017

TCT 13: A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (FUTURE-I) - One-Year Clinical and Imaging Outcomes

Presenter: Stephan Achenbach, Jacques J. Koolen, Bo Xu

October 31, 2017

Advertisement

Exploring Diversity and Generalizability of EXCEL/NOBLE III: Fu-Wai Left Main Registry

Exploring Diversity and Generalizability of EXCEL/NOBLE II: IRIS-MAIN

Exploring Diversity and Generalizability of EXCEL/NOBLE I: DELTA-2

Insights From the PCI Arms in EXCEL and NOBLE: Can the Outcomes Be Further Improved?

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Insights From the CABG Arms in EXCEL and NOBLE: What Met Expectations, What Didnt?

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

Insights From New Meta-Analyses of PCI vs CABG for Left Main Revascularization

ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption

NOBLE: Core Findings Revisited and New Data

ABSORB in STEMI I: TROFI II 3-Year Clinical Outcomes and Correlations With the 6-Month OCT Findings

New Insights From AIDA: Subgroups and Predictors of Adverse Events

TCT 571: Different Tissue Morphology of In-stent Restenosis in Hemodialysis Patient Compared With Non-hemodialysis Patients: A Prospective Multicenter Optical Coherence Tomography Registry

RIBS IV: 3-Year Outcomes From a Randomized Trial of a Metallic DES vs a Drug-Eluting Balloon in Patients With DES Restenosis

Bioresorbable Scaffolds One Year After Approval: FDA Perspectives on Current and Future BRS

Bioresorbable Scaffolds One Year After Approval: Physician-scientist Perspectives on Current and Future BRS

TCT 16: Prospective, Multicenter Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold - Imaging Outcomes and Five-Year Clinical and Imaging Results

ILUMIEN III: 1-Year Outcomes From a Randomized Trial of OCT-Guided vs IVUS-Guided vs Angiography-Guided Stent Implantation

TCT 94: Safety and Efficacy of the Combo Bioegineered Stent in an All-Comer PCI Cohort - Results From the Mascot Postmarketing Registry

TCT 13: A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (FUTURE-I) - One-Year Clinical and Imaging Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content